1. Home
  2. BBIO vs FICO Comparison

BBIO vs FICO Comparison

Compare BBIO & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$75.97

Market Cap

13.3B

Sector

Health Care

ML Signal

N/A

Logo Fair Isaac Corproation

FICO

Fair Isaac Corproation

N/A

Current Price

$698.66

Market Cap

15.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
BBIO
FICO
Founded
2015
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
15.3B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BBIO
FICO
Price
$75.97
$698.66
Analyst Decision
Buy
Buy
Analyst Count
22
21
Target Price
$107.00
★ $821.37
AVG Volume (30 Days)
★ 2.7M
684.1K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 36.85
EPS
N/A
★ 36.32
Revenue
$502,076,000.00
★ $1,032,475,000.00
Revenue This Year
$118.56
$2.20
Revenue Next Year
$51.71
$6.47
P/E Ratio
★ N/A
$18.66
Revenue Growth
★ 126.26
N/A
52 Week Low
$62.50
$595.19
52 Week High
$93.42
$1,858.91

Technical Indicators

Market Signals
Indicator
BBIO
FICO
Relative Strength Index (RSI) 54.92 42.49
Support Level $63.62 $662.30
Resistance Level $80.22 $760.65
Average True Range (ATR) 2.85 34.95
MACD -0.11 1.23
Stochastic Oscillator 36.89 39.71

Price Performance

Historical Comparison
BBIO
FICO

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac is a leading applied analytics company. It is primarily known for its FICO credit scores, a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

Share on Social Networks: